Jakarta - Delayed Quote IDR

PT Bundamedik Tbk (BMHS.JK)

Compare
246.00
-2.00
(-0.81%)
At close: January 17 at 4:00:03 PM GMT+7
Currency in IDR All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,546,344,765.88
1,488,197,483.37
1,658,687,911.22
1,890,800,275.75
1,148,144,381.71
Cost of Revenue
817,507,331.80
792,384,606.26
894,135,274.14
916,779,194.68
654,993,791.22
Gross Profit
728,837,434.08
695,812,877.11
764,552,637.08
974,021,081.07
493,150,590.49
Operating Expense
625,379,194.44
608,104,124.48
548,131,080.60
497,827,263.87
323,823,278.86
Operating Income
103,458,239.65
87,708,752.63
216,421,556.48
476,193,817.20
169,327,311.63
Net Non Operating Interest Income Expense
-49,366,661.37
-49,339,256.14
-38,756,694.92
-17,837,723.61
-48,385,731.93
Pretax Income
54,619,392.60
40,323,055.72
176,790,020.01
457,138,685.52
144,991,937.52
Tax Provision
27,264,888.69
24,093,626.88
47,858,164.35
102,489,898.34
26,531,851.75
Net Income Common Stockholders
30,586,560.38
24,997,723.33
83,227,727.17
214,489,125.59
88,791,039.35
Diluted NI Available to Com Stockholders
30,586,560.38
24,997,723.33
83,227,727.17
214,489,125.59
88,791,039.35
Basic EPS
1.60
0.90
9.70
44.00
10.32
Diluted EPS
1.60
0.90
9.70
44.00
10.32
Basic Average Shares
8,603,416.18
8,603,416.18
8,603,416.18
4,902,833.19
8,603,416.18
Diluted Average Shares
8,603,416.18
8,603,416.18
8,603,416.18
4,902,833.19
8,603,416.18
Rent Expense Supplemental
2,537,019.09
3,141,542.93
1,558,779.32
7,592,276.91
4,300,111.10
Total Expenses
1,442,886,526.23
1,400,488,730.74
1,442,266,354.74
1,414,606,458.55
978,817,070.08
Net Income from Continuing & Discontinued Operation
30,586,560.38
24,997,723.33
83,227,727.17
214,489,125.59
88,791,039.35
Normalized Income
30,174,865.21
23,473,947.13
83,865,743.65
215,433,592.35
90,233,919.28
Interest Income
13,280,957.01
8,424,381.21
8,362,881.29
10,178,168.96
4,733,986.26
Interest Expense
54,864,005.72
49,569,174.94
37,967,217.95
16,085,941.29
43,633,363.94
Net Interest Income
-49,366,661.37
-49,339,256.14
-38,756,694.92
-17,837,723.61
-48,385,731.93
EBIT
109,483,398.32
89,892,230.67
214,757,237.96
473,224,626.81
188,625,301.46
EBITDA
233,117,733.78
203,446,232.50
323,294,453.27
544,634,545.40
246,914,897.64
Reconciled Cost of Revenue
817,507,331.80
792,384,606.26
894,135,274.14
916,779,194.68
654,993,791.22
Reconciled Depreciation
123,634,335.46
113,554,001.83
108,537,215.31
71,409,918.59
58,289,596.19
Net Income from Continuing Operation Net Minority Interest
30,586,560.38
24,997,723.33
83,227,727.17
214,489,125.59
88,791,039.35
Total Unusual Items Excluding Goodwill
527,814.32
1,953,559.23
-874,841.56
-1,217,408.07
-1,766,045.97
Total Unusual Items
527,814.32
1,953,559.23
-874,841.56
-1,217,408.07
-1,766,045.97
Normalized EBITDA
232,589,919.46
201,492,673.27
324,169,294.83
545,851,953.47
248,680,943.61
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
116,119.15
429,783.03
-236,825.08
-272,941.30
-323,166.04
12/31/2020 - 7/6/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers